logo

For the Inventor, By the Inventor

Fort Collins, CO, United States of America

Tolmar Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 24

% Expired Patents = 66.7


Trademarks = 3

Forward Citations = 279

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Richard L Norton (10 out of 33 patents)

silverMedal Eric Dadey (9 out of 22 patents)

bronzeMedal Richard L Dunn (8 out of 68 patents)

4.  John Middleton (6 out of 27 patents)

5.  Kevin Stuart McCann (2 out of 2 patents)

6.  Harish Ravivarapu (2 out of 4 patents)

7.  Bhagya L Chandrashekar (2 out of 7 patents)

8.  Cody L Yarborough (2 out of 9 patents)

9.  Dominic G Madril (2 out of 8 patents)

10.  Lester Moore (2 out of 2 patents)

11.  John Steven Garrett (2 out of 6 patents)

12.  Herbert Robert Brinkman (1 out of 3 patents)

13.  John Milton Downing (1 out of 4 patents)

14.  Eric Mugoye (1 out of 1 patent)

15.  Mingxing Zhou (1 out of 17 patents)


24 patents:

1. 11147880 - Low-burst polymers and methods to produce polymer (2021-10-19),
2. D908916 - Syringe restrictor plate (2021-01-26),
3. 10794632 - Vented cover plate for an array of syringes (2020-10-06),
4. 10744268 - Syringe plunger system with self-locking threaded geometry (2020-08-18),
5. 10206970 - Low-burst polymers and methods to produce polymer (2019-02-19),
6. 10047193 - Sustained release polymer (2018-08-14),
7. 9974824 - Low-burst polymers and methods to produce polymer (2018-05-22),
8. 9914802 - Sustained release polymer (2018-03-13),
9. 9655970 - Low-burst polymers and methods to produce polymers (2017-05-23),
10. 9561282 - Low-burst polymers and methods to produce polymer (2017-02-07),
11. 9539333 - Sustained release polymer (2017-01-10),
12. 9308162 - Biocompatible oligomer-polymer compositions (2016-04-12),
13. 9283282 - Sustained release polymer (2016-03-15),
14. 9254307 - Polymeric delivery formulations of leuprolide with improved efficacy (2016-02-09),
15. 9187593 - Low burst polymers and methods to produce polymer (2015-11-17),
Company Overview
Tolmar Therapeutics, Inc. is a biopharmaceutical company based in Fort Collins, Colorado, specializing in the development and commercialization of innovative therapies for patients with unmet medical needs. The company focuses on areas such as hormone replacement therapy and other specialty pharmaceuticals, leveraging advanced drug delivery technologies. Tolmar is committed to improving patient outcomes through its research and development efforts, aiming to provide effective solutions in the healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

24 Patents

#16 in Fort Collins, CO

#276 in Colorado

#13,918 in US

#26,748 in the World

Fort Collins, CO (US)
Fort Collins, CO, United States of America

Tolmar Therapeutics, Inc.

Forward Citations = 279

21 inventors:

goldMedal Richard L Norton (10 out of 33 patents)

silverMedal Eric Dadey (9 out of 22 patents)

bronzeMedal Richard L Dunn (8 out of 68 patents)

4.  John Middleton (6 out of 27 patents)

5.  Kevin Stuart McCann (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tolmar Therapeutics, Inc.. Retrieved from https://idiyas.com/company/tolmar-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…